Summary

Report Scope:

The rising prevalence of cardiovascular diseases (CVDs) due to changed lifestyles has fueled the market for defibrillators. Lifestyle diseases such as hypertension, obesity, type 2 diabetes, and dyslipidemia are the major risk factors for CVD. CVD prevalence is also increasing due to the growing geriatric population, so the incidence of heart disease is expected to increase. During the last few years, significant improvements have been made in defibrillators. The development of subcutaneous implantable cardioverter-defibrillator (S-ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) is expected to drive market growth during the forecast period. High growth opportunities for defibrillators in emerging markets have also fueled the demand.

This report provides a brief exposure to the defibrillators global market. This report highlights the current and future market potential for this medical equipment and offers a brief analysis of the market's drivers, challenges, and opportunities. Revenues are broken down by region, type, and end user. For market estimates, data has been provided for 2019, 2020 and 2021 (as the base year), projections for 2022, and a forecast for 2027. The report also covers the market share for major market players. It includes the company profiles of the major players, with brief information about their business segments, financials, product portfolios, and recent developments. The report also provides an analysis of the impact of the COvID-19 pandemic on this market.

This report on defibrillators provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies critical medical and geographical challenges and rising opportunities in the developed and developing world.

Report Includes:

- A brief general outlook of the global market for defibrillators
- Analysis of current and future market potential and discussion on the market drivers, challenges, and opportunities
- Analyses of global market trends with data from 2019-2022, and projections of compound annual growth rates (CAGRs) through 2027
- Segmentation of the defibrillators market by type, end use and region
- Insight into the recent industry structure, regulations and policies, pipeline products, and the vendor landscape of the market leading participants

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Market Outlook
1.1 Market Snapshot
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Defibrillators
3.2 Implantable Cardioverter Defibrillators (ICDs)
3.2.1 Transvenous or Traditional ICDs
3.2.2 Subcutaneous ICDs
3.2.3 Cardiac Resynchronization Therapy-Defibrillator
3.3 External Defibrillators
3.3.1 Manual External Defibrillators
3.3.2 Automated External Defibrillators (AEDs)
3.3.3 Wearable Cardioverter Defibrillators (WCDs)
3.4 Market Drivers
3.4.1 Increasing Prevalence of the Cardiac Disorders
3.4.2 Technological Advancements in Defibrillators
3.4.3 Growing Awareness and Government Initiatives
3.5 Market Barriers
3.5.1 Technical Issues in Implantable and Automated External Defibrillators
3.5.2 Lack of Training and Awareness
3.6 Market Opportunities
3.6.1 Rise in Demand for Defibrillators in Emerging Markets
3.6.2 Impact of COVID-19 Pandemic
Chapter 4 Market Breakdown by Type
4.1 Market by Type of Defibrillator
4.1.1 Market Overview
4.1.2 Market Revenue
4.1.3 Implantable Cardioverter Defibrillators
4.1.4 External Defibrillators
Chapter 5 Market Breakdown by End User
5.1 Overview
5.2 Hospitals, Clinics and Cardiac Centers
5.3 Public Access and Pre-hospital
5.4 Home Care
Chapter 6 Market Breakdown by Region
6.1 Introduction
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Mergers, Acquisitions, and Collaborations
7.1.1 Recent Developments in the Market for Defibrillators
7.1.2 Defibrillator Market Shares
7.1.3 FDA approvals for Premarket AEDs in 2019, 2020 and 2021
7.1.4 Recent Product Recalls
Chapter 8 Company Profiles
ABBOTT LABORATORIES
ASAHI KASEI CORP.
BIOTRONIK SE & CO. KG
BOSTON SCIENTIFIC CORP.
DEFIBTECH LLC
LIVANOVA
MEDIANA
MEDTRONIC PLC
NIHON KOHDEN CORP.
PHILIPS MEDICAL CORP.
STRYKER CORP.
Chapter 9 Project Scope and Methodology
9.1 Scope of Report
9.2 Methodology
9.3 Analyst's Credentials
9.4 BCC Custom Research
9.5 Related BCC Research Reports